Literature DB >> 15754169

Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Ewa Olszewska1, Jürgen Lautermann, Can Koc, Matthias Schwaab, Stefan Dazert, Henning Hildmann, Holger Sudhoff.   

Abstract

Pediatric cholesteatoma can be classified as congenital or acquired based on clinical criteria. We studied the expression patterns of five distinctive cytokeratins in both types of cholesteatoma in order to improve understanding of their pathogenesis and origin. A comparable expression pattern for CK10, CK14, CK18, CK19 and 34betaE12 antigens was found in the matrix of congenital and acquired pediatric cholesteatoma. Our results demonstrate that congenital and acquired pediatric cholesteatoma exhibit an identical cytokeratin distribution pattern, suggesting that they share a common origin. Therefore, it seems possible that a portion of the so-called "acquired" cholesteatoma may actually originate from advanced congenital cholesteatoma with secondary destruction of the tympanic membrane in the pediatric patient population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15754169     DOI: 10.1007/s00405-004-0875-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  49 in total

1. 

Authors:  Holger Sudhoff; H Hildmann
Journal:  HNO       Date:  2003-01       Impact factor: 1.284

2.  Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.

Authors:  C A Van Blitterswijk; J J Grote; R W Lutgert; S C Hesseling; C J Out; G N Van Muijen; J A Fransen
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-08       Impact factor: 1.547

3.  Changes in keratinocyte maturation during wound healing.

Authors:  J N Mansbridge; A M Knapp
Journal:  J Invest Dermatol       Date:  1987-09       Impact factor: 8.551

4.  Cellular differentiation of the middle ear lining.

Authors:  J Sadé
Journal:  Ann Otol Rhinol Laryngol       Date:  1971-06       Impact factor: 1.547

5.  Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.

Authors:  J Bujía; V Schilling; A Holly; M Stammberger; E Kastenbauer
Journal:  Acta Otolaryngol       Date:  1993-05       Impact factor: 1.494

6.  Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology.

Authors:  F Ramaekers; A Huysmans; O Moesker; A Kant; P Jap; C Herman; P Vooijs
Journal:  Lab Invest       Date:  1983-09       Impact factor: 5.662

7.  The natural history of congenital cholesteatoma.

Authors:  Peter J Koltai; Marc Nelson; Roberto J Castellon; Erea-Noel Garabedian; Jean-Michel Triglia; Stephane Roman; Gilles Roger
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

Review 8.  Congenital cholesteatomas of the middle ear in children: origin and management.

Authors:  M J Levenson; L Michaels; S C Parisier
Journal:  Otolaryngol Clin North Am       Date:  1989-10       Impact factor: 3.346

9.  Intramembranous and mesotympanic cholesteatomas associated with an intact tympanic membrane in children.

Authors:  S M Sobol; T J Reichert; K D Faw; M H Stroud; G J Spector; J H Ogura
Journal:  Ann Otol Rhinol Laryngol       Date:  1980 Jul-Aug       Impact factor: 1.547

10.  Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes.

Authors:  R A Weiss; R Eichner; T T Sun
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

View more
  8 in total

1.  Galectin-1, -3, -7 expressions in congenital and acquired pediatric cholesteatomas compared to external auditory canal skin.

Authors:  Marc Vander Ghinst; Myriam Remmelink; Anne-Laure Mansbach; Sergio Hassid; Georges Choufani
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-06-12       Impact factor: 3.372

2.  Apoptosis in the pathogenesis of cholesteatoma in adults.

Authors:  Ewa Olszewska; Stanislaw Chodynicki; Lech Chyczewski
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-12-24       Impact factor: 2.503

3.  [Current aspects of paediatric cholesteatomas].

Authors:  J P Thomas; S Volkenstein; A Minovi; S Dazert
Journal:  HNO       Date:  2013-05       Impact factor: 1.284

4.  Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.

Authors:  Hans-J Welkoborsky; Roland S Jacob; Mike L Hinni
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-01       Impact factor: 2.503

5.  Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.

Authors:  Taichi Kan; Hiromi Ueda; Taishi Takahara; Yoshimasa Tsuchiya; Mayuko Kishimoto; Yasue Uchida; Tetsuya Ogawa; Wataru Ohashi; Toyonori Tsuzuki; Yasushi Fujimoto
Journal:  Biomed Res Int       Date:  2021-03-10       Impact factor: 3.411

6.  Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma.

Authors:  Enikő Palkó; Szilárd Póliska; István Sziklai; András Penyige
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

7.  Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma.

Authors:  Hyun Jung Min; Chul Won Park; Jin Hyeok Jeong; Seok Hyun Cho; Kyung Rae Kim; Seung Hwan Lee
Journal:  Korean J Audiol       Date:  2012-12-18

8.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.